Equity Overview
Price & Market Data
Price: $2.61
Daily Change: -$0.14 / 5.36%
Daily Range: $2.56 - $2.97
Market Cap: $98,702,728
Daily Volume: 32,594
Performance Metrics
1 Week: -4.68%
1 Month: -0.38%
3 Months: 10.42%
6 Months: -47.42%
1 Year: -65.63%
YTD: -67.44%
Company Details
Employees: 64
Sector: Health services
Industry: Medical/Nursing services
Country:
Details
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.